🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
2.740
-0.145 (-5.03%)
At close: Nov 20, 2026, 4:00 PM EST
2.730
-0.010 (-0.36%)
After-hours: Nov 20, 2026, 7:30 PM EST

Verrica Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Verrica Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $13.67. The average 1-year stock price forecast is 398.91% higher than the current stock price, while the lowest is $9.00 (+228.47%) and the highest is $20 (+629.93%).

Price Target: $13.67 (+398.91%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$9.00$13.67$12.5$20
Change+228.47%+398.91%+356.20%+629.93%

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy555665
Buy000000
Hold111110
Sell000000
Strong Sell000000
Total666775

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$12
BuyReiterates$12+337.96%Nov 19, 2026
Needham
Needham
Hold
Maintains
n/a
HoldMaintainsn/an/aNov 13, 2026
TD Cowen
TD Cowen
Buy
Maintains
$3.72 → $20
BuyMaintains$3.72 → $20+629.93%Nov 13, 2026
Lake Street
Lake Street
Buy
Maintains
$9
BuyMaintains$9+228.47%Sep 30, 2026
Brookline Capital Markets
Brookline Capital Markets
Buy
Upgrades
$17
BuyUpgrades$17+520.44%Dec 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
24.79M
from 35.58M
Decreased by -30.32%
Revenue Next Year
36.47M
from 24.79M
Increased by 47.12%
EPS This Year
-2.01
from -1.24
EPS Next Year
-1.37
from -2.01
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
12.00M9.03M5.12M7.57M35.58M24.79M
Revenue Growth
--24.73%-43.27%47.66%370.22%-30.32%
Operating Income
-30.91M-21.30M-63.22M-65.84M-11.94M-45.59M
Net Income
-35.08M-24.49M-67.00M-76.58M-17.89M-48.23M
EPS
-----1.24-2.01
Free Cash Flow
-----17.63M-21.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High25.3M
Avg24.8M
Low24.1M

Revenue Growth

Revenue Growth202620272028
High
-28.9%
Avg
-30.3%
Low
-32.3%

EPS Forecast

EPS202620272028
High-1.88
Avg-2.01
Low-2.24

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-